共 84 条
[1]
Powers WJ(2020)Acute ischemic stroke N Engl J Med 383 252-260
[2]
Powers WJ(2018)2018 guidelines for the early management of patients with acute ischemic stroke: a guideline for healthcare professionals from the American Heart Association/American Stroke Association Stroke 49 e46-e110
[3]
Rabinstein AA(2010)Low rates of acute recanalization with intravenous recombinant tissue plasminogen activator in ischemic stroke: real-world experience and a call for action Stroke 41 2254-2258
[4]
Ackerson T(2002)Pharmacokinetics and pharmacodynamics of tenecteplase in fibrinolytic therapy of acute myocardial infarction Clin Pharmacokinet 41 1229-1245
[5]
Bhatia R(1998)TNK-tissue plasminogen activator compared with front-loaded alteplase in acute myocardial infarction: results of the TIMI 10B trial. Thrombolysis in Myocardial Infarction (TIMI) 10B Investigators Circulation 98 2805-2814
[6]
Hill MD(2018)2017 ESC Guidelines for the management of acute myocardial infarction in patients presenting with ST segment elevation: the Task Force for the management of acute myocardial infarction in patients presenting with ST-segment elevation of the European Society of Cardiology (ESC) Eur Heart J 39 119-177
[7]
Shobha N(2018)Tenecteplase versus alteplase before thrombectomy for ischemic stroke N Engl J Med 378 1573-1582
[8]
Tanswell P(2010)Phase IIB/III trial of tenecteplase in acute ischemic stroke: results of a prematurely terminated randomized clinical trial Stroke 41 707-711
[9]
Modi N(2015)Alteplase versus tenecteplase for thrombolysis after ischaemic stroke (ATTEST): a phase 2, randomised, open-label, blinded endpoint study Lancet Neurol 14 368-376
[10]
Combs D(2021)Real-world comparative safety and efficacy of tenecteplase versus alteplase in acute ischemic stroke patients with large vessel occlusion Ther Adv Neurol Disord 14 1756286420986727-299